Polycystic kidney disease medical therapy

Polycystic kidney disease Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Polycystic kidney disease from other Diseases
Epidemiology and Demographics
Risk Factor
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Interventions
Surgery
Primary Prevention
Secondary Prevention
Future or Investigational Therapies
Case Studies
Case #1
Polycystic kidney disease medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Polycystic kidney disease medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Polycystic kidney disease medical therapy
CDC on Polycystic kidney disease medical therapy
Polycystic kidney disease medical therapy in the news
Blogs on Polycystic kidney disease medical therapy
Directions to Hospitals Treating Polycystic kidney disease
Risk calculators and risk factors for Polycystic kidney disease medical therapy

Steven C. Campbell, M.D., Ph.D. Cafer Zorkun, M.D., Ph.D. [1]

Treatment

Treatment of ADPKD is targeted at managing symptoms and disease complications. There have been no treatments associated with disease regression or slowing of cysts formation.